This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Infertility or Poor Ovarian Response
and you are a woman who is
between 18 and 45
years old
Phase
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of the present study is to examine the level of ovarian response and the pregnancy rates among poor ovarian responders treated with a novel treatment protocol with 150μg corifollitropin alfa followed by 300IU hMG in a long GnRH agonist protocol.

Provided treatments

  • Drug: Triptorelin
  • Drug: Corifollitropin alfa 150μg
  • Drug: hpHMG
Tris trial is registered with FDA with number: NCT01732094. The sponsor of the trial is Universitair Ziekenhuis Brussel and it is looking for 57 volunteers for the current phase.
Official trial title:
Phase II Study of Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders